33.85
price down icon0.62%   -0.21
 
loading
Surmodics Inc stock is traded at $33.85, with a volume of 65,342. It is down -0.62% in the last 24 hours and down -13.16% over the past month.
See More
Previous Close:
$34.06
Open:
$33.89
24h Volume:
65,342
Relative Volume:
0.50
Market Cap:
$549.47M
Revenue:
$138.20M
Net Income/Loss:
$5.52M
P/E Ratio:
89.08
EPS:
0.38
Net Cash Flow:
$9.86M
1W Performance:
-0.56%
1M Performance:
-13.16%
6M Performance:
-17.54%
1Y Performance:
+9.90%
1-Day Range:
Value
$33.84
$34.26
1-Week Range:
Value
$32.97
$34.97
52-Week Range:
Value
$25.17
$42.44

Surmodics Inc Stock (SRDX) Company Profile

Name
Name
Surmodics Inc
Name
Phone
(952) 500-7000
Name
Address
9924 W 74TH ST, EDEN PRAIRIE, MN
Name
Employee
0
Name
Twitter
Name
Next Earnings Date
2024-11-06
Name
Latest SEC Filings
Name
SRDX's Discussions on Twitter

Compare SRDX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Medical Devices icon
SRDX
Surmodics Inc
33.85 549.47M 138.20M 5.52M 9.86M 0.38
Medical Devices icon
ABT
Abbott Laboratories
129.13 222.39B 41.95B 13.40B 6.49B 7.65
Medical Devices icon
BSX
Boston Scientific Corp
105.22 154.78B 15.91B 1.79B 1.89B 1.21
Medical Devices icon
SYK
Stryker Corp
391.16 150.99B 22.60B 2.99B 3.49B 7.76
Medical Devices icon
MDT
Medtronic Plc
89.59 116.46B 33.00B 4.29B 5.50B 3.27
Medical Devices icon
EW
Edwards Lifesciences Corp
70.61 41.87B 6.60B 4.16B 490.10M 6.93

Surmodics Inc Stock (SRDX) Upgrades & Downgrades

Date Action Analyst Rating Change
Jun-13-23 Upgrade Needham Hold → Buy
Feb-13-23 Downgrade Needham Buy → Hold
Jul-23-20 Upgrade Needham Hold → Buy
Dec-11-19 Downgrade Needham Buy → Hold
Nov-01-19 Downgrade Lake Street Buy → Hold
Aug-01-19 Reiterated Needham Buy
May-02-19 Reiterated Lake Street Buy
May-02-19 Reiterated Needham Buy
Feb-21-19 Reiterated Needham Buy
May-16-18 Reiterated Needham Buy
Mar-01-18 Upgrade Sidoti Neutral → Buy
Feb-28-18 Reiterated Lake Street Buy
Feb-28-18 Initiated Needham Buy
Jul-14-17 Initiated Lake Street Buy
Nov-21-16 Downgrade Barrington Research Outperform → Mkt Perform
Oct-06-16 Downgrade Sidoti Buy → Neutral
May-03-16 Reiterated Barrington Research Outperform
Aug-06-15 Reiterated Barrington Research Outperform
Mar-27-15 Initiated Dougherty & Company Buy
Feb-25-14 Initiated Laidlaw Buy
Aug-01-13 Upgrade Feltl & Co. Buy → Strong Buy
Nov-12-12 Reiterated Barrington Research Outperform
View All

Surmodics Inc Stock (SRDX) Latest News

pulisher
05:44 AM

Surmodics Q2 EPS Estimate Decreased by Barrington Research - MarketBeat

05:44 AM
pulisher
Feb 06, 2025

Top 3 Health Care Stocks You'll Regret Missing This Month - Benzinga

Feb 06, 2025
pulisher
Feb 04, 2025

Ratios in Focus: Analyzing Surmodics, Inc (SRDX)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Feb 04, 2025
pulisher
Feb 04, 2025

Surmodics' (SRDX) "Hold" Rating Reaffirmed at Needham & Company LLC - MarketBeat

Feb 04, 2025
pulisher
Feb 04, 2025

Surmodics (NASDAQ:SRDX) Posts Earnings Results, Beats Estimates By $0.04 EPS - MarketBeat

Feb 04, 2025
pulisher
Feb 03, 2025

What is Zacks Research's Estimate for Surmodics Q2 Earnings? - MarketBeat

Feb 03, 2025
pulisher
Feb 03, 2025

SurModics (SRDX) Loses -13.87% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance

Feb 03, 2025
pulisher
Feb 03, 2025

Surmodics Announces Successful Early Clinical Use of Pounce™ XL Thrombectomy System, Suitable for Non-Surgical Removal of Thrombi and Emboli from Iliac and Femoral Arteries - Business Wire

Feb 03, 2025
pulisher
Feb 03, 2025

Surmodics (NASDAQ:SRDX) Now Covered by StockNews.com - Defense World

Feb 03, 2025
pulisher
Feb 03, 2025

Barrington Research Lowers Earnings Estimates for Surmodics - Defense World

Feb 03, 2025
pulisher
Feb 03, 2025

Surmodics (SRDX) Expected to Announce Earnings on Thursday - MarketBeat

Feb 03, 2025
pulisher
Feb 02, 2025

Surmodics, Inc. (NASDAQ:SRDX) Sees Large Growth in Short Interest - MarketBeat

Feb 02, 2025
pulisher
Feb 01, 2025

Surmodics (NASDAQ:SRDX) Trading Down 5.5%Time to Sell? - MarketBeat

Feb 01, 2025
pulisher
Feb 01, 2025

Zacks Research Has Positive Outlook of Surmodics Q2 Earnings - Defense World

Feb 01, 2025
pulisher
Jan 31, 2025

Surmodics Stock Down Despite Q1 Earnings Beat, Gross Margin Up - MSN

Jan 31, 2025
pulisher
Jan 31, 2025

Zacks Research Increases Earnings Estimates for Surmodics - Defense World

Jan 31, 2025
pulisher
Jan 30, 2025

SurModics: Fiscal Q1 Earnings Snapshot - CT Insider

Jan 30, 2025
pulisher
Jan 30, 2025

Surmodics Reports Q1 Loss and Strategic Moves - TipRanks

Jan 30, 2025
pulisher
Jan 30, 2025

SurModics (SRDX) Reports Q1 Loss, Misses Revenue Estimates - MSN

Jan 30, 2025
pulisher
Jan 30, 2025

Surmodics Reports First Quarter of Fiscal Year 2025 Financial Results - BioSpace

Jan 30, 2025
pulisher
Jan 30, 2025

Surmodics Earnings Analysis: Q1 Recap - Benzinga

Jan 30, 2025
pulisher
Jan 30, 2025

Surmodics Inc. (SRDX) reports earnings - Quartz

Jan 30, 2025
pulisher
Jan 30, 2025

Surmodics Inc Reports Q1 FY2025 EPS of $(0.26) and Revenue of $2 - GuruFocus.com

Jan 30, 2025
pulisher
Jan 30, 2025

SurModics: Fiscal Q1 Earnings Snapshot -January 30, 2025 at 07:25 am EST - Marketscreener.com

Jan 30, 2025
pulisher
Jan 30, 2025

Surmodics' $627M Merger in Focus as New FDA Approval Offsets Revenue Decline - StockTitan

Jan 30, 2025
pulisher
Jan 30, 2025

Surmodics (SRDX) to Release Earnings on Thursday - Defense World

Jan 30, 2025
pulisher
Jan 29, 2025

Here's Why You Should Add Surmodics Stock to Your Portfolio Now - MSN

Jan 29, 2025
pulisher
Jan 28, 2025

Surmodics falls on report about FTC review of GTCR deal - Seeking Alpha

Jan 28, 2025
pulisher
Jan 26, 2025

Surmodics (NASDAQ:SRDX) Coverage Initiated by Analysts at StockNews.com - Defense World

Jan 26, 2025
pulisher
Jan 23, 2025

JPMorgan Chase & Co. Buys 27,960 Shares of Surmodics, Inc. (NASDAQ:SRDX) - Defense World

Jan 23, 2025
pulisher
Jan 14, 2025

After Plunging -10.42% in 4 Weeks, Here's Why the Trend Might Reverse for SurModics (SRDX) - Yahoo Finance

Jan 14, 2025
pulisher
Jan 13, 2025

Surmodics drops after report on FTC's view on planned sale to GTCR (SRDX:NASDAQ) - Seeking Alpha

Jan 13, 2025
pulisher
Jan 11, 2025

Matterport, Surmodics drop amid news of FTC closed door meeting next week - MSN

Jan 11, 2025
pulisher
Jan 10, 2025

Surmodics (SRDX) Shares Cross Below 200 DMA - Nasdaq

Jan 10, 2025
pulisher
Jan 10, 2025

Matterport, Surmodics drop amid news of FTC closed door meeting next week (MTTR:NASDAQ) - Seeking Alpha

Jan 10, 2025
pulisher
Jan 10, 2025

Surmodics (NASDAQ:SRDX) Earns Hold Rating from Analysts at StockNews.com - Defense World

Jan 10, 2025
pulisher
Jan 09, 2025

Surmodics (FRA:SU6) 5-Day RSI : 39.40 (As of Jan. 09, 2025) - GuruFocus.com

Jan 09, 2025
pulisher
Jan 07, 2025

AtriCure (NASDAQ:ATRC) versus Surmodics (NASDAQ:SRDX) Head to Head Analysis - Defense World

Jan 07, 2025

Surmodics Inc Stock (SRDX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Surmodics Inc Stock (SRDX) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Arens Timothy J.
Chief Financial Officer
Nov 26 '24
Sale
39.44
7,009
276,453
70,350
medical_devices ZBH
$100.67
price down icon 1.97%
medical_devices STE
$221.80
price down icon 1.53%
medical_devices PHG
$27.30
price down icon 0.51%
$87.78
price down icon 0.74%
$87.77
price down icon 0.98%
medical_devices EW
$70.71
price down icon 0.31%
Cap:     |  Volume (24h):